Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 14, Issue 675, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-12-15
DOI
10.1126/scitranslmed.abq0021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer
- (2022) Yi Wang et al. SEMINARS IN CANCER BIOLOGY
- First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
- (2021) Luis Paz-Ares et al. LANCET ONCOLOGY
- Beyond immune checkpoint blockade: emerging immunological strategies
- (2021) Shawn P. Kubli et al. NATURE REVIEWS DRUG DISCOVERY
- Pemetrexed Plus Platinum With or Without Pembrolizumab in Patients With Previously Untreated Metastatic Nonsquamous NSCLC: Protocol-Specified Final Analysis From KEYNOTE-189
- (2021) D. Rodríguez-Abreu et al. ANNALS OF ONCOLOGY
- Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small cell lung cancer
- (2021) A.J. Schoenfeld et al. ANNALS OF ONCOLOGY
- Current issues and perspectives in PD-1 blockade cancer immunotherapy
- (2020) Kenji Chamoto et al. International Journal of Clinical Oncology
- Acquired Resistance to Immune Checkpoint Inhibitors
- (2020) Adam J. Schoenfeld et al. CANCER CELL
- Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinity
- (2020) Inga Kavazović et al. PLOS BIOLOGY
- Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
- (2020) Luana Guerra et al. Cell Reports
- Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non‐transformed and cancer cells
- (2020) Philippe Marchetti et al. FASEB JOURNAL
- Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
- (2020) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
- (2019) K Hastings et al. ANNALS OF ONCOLOGY
- Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
- (2019) Edward B. Garon et al. JOURNAL OF CLINICAL ONCOLOGY
- PGC-1α activator–induced fatty acid oxidation in tumor-infiltrating CTLs enhances effects of PD-1 blockade therapy in lung cancer
- (2019) Huan Wan et al. TUMORI
- Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan
- (2019) Ryo Morita et al. LUNG CANCER
- Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study
- (2018) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- PPAR-induced fatty acid oxidation in T cells increases the number of tumor-reactive CD8+ T cells and facilitates anti-PD-1 therapy
- (2018) Partha S. Chowdhury et al. Cancer Immunology Research
- Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
- (2018) Hanjie Li et al. CELL
- Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers
- (2018) Michael Offin et al. CLINICAL CANCER RESEARCH
- Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy
- (2017) P. S. Chowdhury et al. JOURNAL OF INTERNAL MEDICINE
- Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
- (2017) Kenji Chamoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD80 Expressed by CD8+ T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8+ T Cells
- (2017) Meagan R. Rollins et al. Journal of Immunology Research
- The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders
- (2016) Sander M. Houten et al. Annual Review of Physiology
- The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
- (2016) Nicole E. Scharping et al. IMMUNITY
- A batch correction method for liquid chromatography–mass spectrometry data that does not depend on quality control samples
- (2016) Martin Rusilowicz et al. Metabolomics
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- T cell metabolism drives immunity
- (2015) Michael D. Buck et al. JOURNAL OF EXPERIMENTAL MEDICINE
- When Too Much ATP Is Bad for Protein Synthesis
- (2015) Mauricio H. Pontes et al. JOURNAL OF MOLECULAR BIOLOGY
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Characterising and correcting batch variation in an automated direct infusion mass spectrometry (DIMS) metabolomics workflow
- (2013) J. A. Kirwan et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- The Paradox of Akt-mTOR Interactions
- (2013) Lakshmipathi Vadlakonda et al. Frontiers in Oncology
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory Development
- (2011) Gerritje J.W. van der Windt et al. IMMUNITY
- Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
- (2011) Warwick B Dunn et al. Nature Protocols
- Alternative memory in the CD8 T cell lineage
- (2011) You Jeong Lee et al. TRENDS IN IMMUNOLOGY
- CRTAM Confers Late-Stage Activation of CD8+ T Cells to Regulate Retention within Lymph Node
- (2009) A. Takeuchi et al. JOURNAL OF IMMUNOLOGY
- Enhancing CD8 T-cell memory by modulating fatty acid metabolism
- (2009) Erika L. Pearce et al. NATURE
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Transcriptional control of mitochondrial biogenesis: the central role of PGC-1
- (2008) R. Ventura-Clapier et al. CARDIOVASCULAR RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now